Circulating levels of tumour necrosis factor, interleukin 6 and proteolytic activity in a murine model of burn and infection.

Cytokines and proteinases have both been implicated as mediators in the inflammatory response associated with trauma and sepsis. Using a burned-infected mouse model, it was previously found that mortality is proportional to the amount of proteolytic activity (PA) in the circulation. However, little is known about circulating cytokine levels in hosts that are both burned and infected. With this mouse model, both tumour necrosis factor (TNF) and interleukin 6 (IL-6) were upregulated by a burn and by an infection. Burn plus infection produced an additive effect on each cytokine, but IL-6 levels correlated better with mortality. Treating mice with the proteinase inhibitor aprotinin immediately preburn and infectious challenge significantly decreased IL-6, PA and mortality. This may be a clinically relevant model for studying mediators in burned and/or septic hosts.

[1]  P. Barie,et al.  Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. , 1990, Surgery, gynecology & obstetrics.

[2]  C. Natanson,et al.  Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis , 1994, Annals of Internal Medicine.

[3]  A. Aasen,et al.  Uncontrolled plasma proteolysis: a major threat to the septicemic patient. , 1986, Resuscitation.

[4]  R. Miller,et al.  Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition , 1994, Infection and immunity.

[5]  I. Maruyama,et al.  Marked increase in plasma interleukin-6 in burn patients. , 1992, The Journal of laboratory and clinical medicine.

[6]  R. Bone,et al.  Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.

[7]  R. Winchurch,et al.  Increased levels of circulating interleukin 6 in burn patients. , 1990, Clinical immunology and immunopathology.

[8]  D. Dunn,et al.  Decreased tumor necrosis factor production during the initial stages of infection correlates with survival during murine gram-negative sepsis. , 1990, Archives of surgery.

[9]  G. Mancuso,et al.  Production of tumor necrosis factor-alpha and interleukin-6 in mice infected with group B streptococci. , 1992, Circulatory shock.

[10]  C. Hack,et al.  Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern , 1993, Infection and immunity.

[11]  B. Risberg,et al.  Early activation of humoral proteolytic systems in patients with multiple trauma , 1986, Critical care medicine.

[12]  R. Colman,et al.  Hemostasis and Thrombosis: Basic Principles and Clinical Practice , 1988 .

[13]  J. Schellekens,et al.  Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon-α, and Interferon-γ in the Serum of Patients with Septic Shock , 1990 .

[14]  C. Hack,et al.  Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. , 1991, Surgery.

[15]  R. Miller,et al.  Surgical trauma, Candida infection, and serum proteolytic activity. , 1992, The Journal of surgical research.

[16]  F. Shofer,et al.  Plasma cytokine determinations in emergency department patients as a predictor of bacteremi and infectious disease severity , 1994, Critical care medicine.

[17]  A. Drost,et al.  Plasma cytokines after thermal injury and their relationship to infection. , 1993 .

[18]  N. Kelly,et al.  Interleukin-6 is a better marker of lethality than tumor necrosis factor in endotoxin treated mice. , 1992, FEMS microbiology immunology.

[19]  R. Tompkins,et al.  Circulating interleukin‐1β and tumor necrosis factor‐α concentrations after burn injury in humans , 1992 .

[20]  D. Rosengarten,et al.  Prophylaxis of post-traumatic pulmonary insufficiency by protease-inhibitor therapy with aprotinin: a clinical study. , 1982, Circulatory shock.

[21]  P. Abbet,et al.  Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide. , 1992, Journal of immunology.

[22]  A. Billiau,et al.  Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock , 1991, European journal of clinical investigation.

[23]  G. Warden,et al.  Components of the increased circulating proteolytic activity in pediatric burn patients. , 1992, The Journal of trauma.

[24]  L. Aarden,et al.  Functional discrimination between interleukin 6 and interleukin 1 , 1988, European journal of immunology.

[25]  B. Hazenberg,et al.  Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute‐phase proteins during the treatment of severe sepsis in humans , 1992, Critical care medicine.

[26]  L. Moldawer.  Biology of proinflammatory cytokines and their antagonists. , 1994, Critical care medicine.

[27]  A. Suffredini.  Current prospects for the treatment of clinical sepsis. , 1994, Critical care medicine.

[28]  J. L. Rodriguez,et al.  Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. , 1992, The Journal of trauma.

[29]  R. Gamelli,et al.  Interleukin-2 and interleukin-6 in relation to burn wound size in the acute phase of thermal injury. , 1994, Journal of the American College of Surgeons.

[30]  A. Neely,et al.  Plasma proteolytic activity following burns. , 1988, The Journal of trauma.

[31]  N. Kelly,et al.  Differential induction of tumor necrosis factor by bacteria expressing rough and smooth lipopolysaccharide phenotypes , 1991, Infection and immunity.

[32]  L. G. Thijs,et al.  Increased plasma levels of interleukin-6 in sepsis [see comments] , 1989 .

[33]  T. Emerson,et al.  Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia. , 1989, American Journal of Medicine.

[34]  J. Blenkharn,et al.  Pathologic and hemodynamic sequelae of unilobar biliary obstruction and associated liver atrophy. , 1991, Surgery.

[35]  I. A. Holder,et al.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. , 1975, The Journal of infectious diseases.

[36]  M. Jochum,et al.  Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery. , 1985, Surgery.

[37]  B. Beutler,et al.  Cachectin: more than a tumor necrosis factor. , 1987, The New England journal of medicine.

[38]  R. Colman.  The role of plasma proteases in septic shock. , 1989, The New England journal of medicine.

[39]  P. Brandtzaeg,et al.  Brief Definitive Report the Complex Pattern of Cytokines in Serum from Patients with Meningococcal Septic Shock Association between Interleukin 6, Interleukin 1, and Fatal Outcome , 2022 .

[40]  U. Bergmann,et al.  Interleukin 6--a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells. , 1991, The Journal of trauma.